Africa News Line Monday, 10.03.2022, 5:22 AM
Welcome Guest | RSS
Site menu

Main » 2022 » June » 20

Industry Leaders Will Discuss Risk and How GIS Can Help Plan for a Safer Future
       

REDLANDS, Calif-Saturday 18 June 2022 [ AETOS Wire ]

(BUSINESS WIRE) -- Esri, the global leader in location intelligence, today announced the detailed agenda of the 2022 Safety and Security Summit @ Esri UC, the world's largest GIS event dedicated to public safety, emergency management, and national security.

Formerly the National Security and Public Safety Summit (NSPSS), the event is part of Esri User Conference (Esri UC), a gathering that brings together GIS users seeking to meet challenges in their organizations and throughout the world, using the most powerful mapping and analytics platform on the planet.

The Safety and Security Summit @ Esri UC is an opportunity for public safety professionals to collaborate and learn how location intelligence provides a road map to resilience in a world with risks that are more complex, intercon ... Read more »

Views: 24 | Added by: africa-live | Date: 06.20.2022 | Comments (0)

GENEVA-Tuesday 14 June 2022 [ AETOS Wire ] (BUSINESS WIRE) -- KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, announced today that an expanded, fully-integrated mammalian contract development and manufacturing services facility is now open and operational in Geneva, Switzerland. The ~94,000 square-foot integrated KBI/Selexis state-of-the-art facility builds upon the companies’ existing market foothold by combining best-in-class cell line development (CLD) and expert mammalian cell manufacturing in a single location. KBI and Selexis leverage their expertise and efficient end-to-end services for biomanufacturing clients. This expansion enables industry-leading delivery of client programs through increased quality, efficiency, and time savings across a diverse portfolio of molecule formats. Under one roof, KBI and Selexis provide cell line transfection through cGMP drug manufacturing with Selexis’ specialized high-titer mammalian cell line development technolog ... Read more »
Views: 38 | Added by: africa-live | Date: 06.20.2022

Search

Entries archive

Calendar